PARIS and Waltham, MA – Feb. 13, 2023 – The growing prevalence of fatty liver disease in the U.S. has led the American Association for the Study of Liver Diseases (AASLD) to call for expanded use of ...
Once almost exclusively seen in older adults, fatty liver disease, which can be fatal if untreated, is now one of the world’s ...
WALTHAM, Mass.--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan family of products, joins the American Liver Foundation, in observance of Liver Cancer Awareness Month, ...
The Quiet Epidemic Taking a Toll on Liver Health: Community event aims to raise awareness about Non-Alcoholic Fatty Liver Disease and the importance of liver health. LONDON, Ontario--(BUSINESS ...
It’s often, “silent” – meaning it rarely presents with symptoms. Until it is severe. It is projected to be the number one cause of liver transplantation in the United States by the year 2030. And it’s ...
Metabolic dysfunction-associated steatotic liver disease (MASLD), nonalcoholic fatty liver disease (NAFLD), and fatty liver disease all describe conditions where too much fat builds up in the liver, ...
PARIS and WALTHAM, Mass., June 7, 2023 /PRNewswire/ -- Most people don't show symptoms of liver disease until it has progressed to an advanced stage, at which point no treatments are available. To ...
Much of the focus on diabetes complications centers on cardiovascular disease and chronic kidney disease, but a fast-emerging area of inquiry is the association of diabetes with liver ...
Phase 3 MAESTRO-NAFLD-1 data demonstrate the potential of resmetirom for the treatment of patients with compensated NASH cirrhosis Screening data from the Phase 3 MAESTRO-NASH biopsy study provide new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback